COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves

Abstract

Many elderly patients with severe SARS-CoV-2 infections and COVID-19 infections are admitted to intensive care units. Age was previously identified as an independent risk factor for death and contributed to the greater severity of COVID-19. The elderly may have diminished lung functions, poor reactions to artificial ventilation, and compromised immune systems. However, it is yet uncertain how each pandemic wave and the predominant SARS-CoV-2 strains contribute to varying results and how patient groups such as the elderly are impacted. Comparing six COVID-19 pandemic waves, the objective of this study was to examine the variation in case severity, symptomatology, ICU hospitalizations, and mortality among SARS-CoV-2-infected elderly individuals. The study followed a retrospective design, including 60 eligible patients older than 70 years in each of the six pandemic wave groups, after matching them by the number of comorbidities and gender. SARS-CoV-2 infection during the first, third, and fourth pandemic waves had a significantly higher risk of mortality for hospitalized patients. Confusion and dyspnea at admission were significant risk factors for ICU admission in elderly patients (β = 1.92, respectively β = 3.65). The laboratory parameters identified decreased lymphocytes (β = 2.11), elevated IL-6 (β = 1.96), and procalcitonin (β = 2.46) as the most significant risk factors. The third and fourth COVID-19 waves had considerably more severe infections (31.7% and 26.7%) than the sixth wave (13.3%). Median ICU stay and percentage of patients receiving oxygen support also differed across pandemic waves. However, mortality rates between the six pandemic waves were similar. The average length of hospitalization varied dramatically among the six pandemic waves. Although senior patients are more likely to have worse COVID-19 outcomes after hospitalization, this risk is mitigated by the greater prevalence of comorbidities and frailty among the elderly. The six pandemic waves that were specifically evaluated did not reveal considerably disproportionate variations in terms of patient mortality; however, during the fourth pandemic wave, there were likely more hospitalized patients with severe COVID-19 in Romania. It is probable that certain circulating SARS-CoV-2 strains were more infectious, resulting in an increase in infections and a strain on healthcare systems, which might explain the variations found in our research.

Exploratory Evaluation of Pre-Treatment Inflammation Profiles in Patients with Colorectal Cancer

“…The timeframe of our study includes the COVID-19 pandemic, during which surgical interventions decreased by over 50% in the first year compared to the pre-pandemic period, in line with global trends [ 13 , 14 , 15 ]. To mitigate potential interference with results due to the impact of SARS-CoV-2 infection on the inflammatory system [ 16 , 17 , 18 ], patients with a history of SARS-CoV-2 infection or those who acquired the infection during hospitalization were excluded from the study.…”

A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome

“… 9–11 With coronavirus disease (COVID-19), initial evidence suggests that Long-COVID symptoms can encompass a wide range of health issues, with neurological and psychological manifestations being among the most frequently reported. 12–14 …”

Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis

“…The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to significant global morbidity and mortality, posing substantial public health challenges [ 1 , 2 , 3 , 4 , 5 ]. As of November 2023, over 13 billion doses of COVID-19 vaccines have been administered worldwide, representing a monumental effort in the history of medicine [ 6 , 7 , 8 ].…”